# Lixin Zhang, M.D. – FDA Inspection, Dec 19, 2025

Source: https://www.keypedia.com/records/fda_inspections/lixin-zhang-md/583baf93-c627-464d-9e67-067ad471f9eb
Source feed: FDA_Inspections

> FDA inspection 1295998 of Lixin Zhang, M.D., December 19, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1295998
- Company Name: Lixin Zhang, M.D.
- Inspection Date: 2025-12-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New York District Office
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/benton-m-ketron/34d763d8-4374-4c8b-8dd6-dce1a83dcd01)

Company: https://www.keypedia.com/companies/lixin-zhang-md/26431f1a-9655-46af-b366-759e679af56c

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d